Encorafenib and binimetinib followed by radiotherapy for patients with BRAFV600-mutant melanoma and brain metastases (E-BRAIN/GEM1802 phase II study).

Autor: Márquez-Rodas, Iván, Álvarez, Ana, Arance, Ana, Valduvieco, Izaskun, Berciano-Guerrero, Miguel-Ángel, Delgado, Raquel, Soria, Ainara, Campos, Fernándo Lopez, Sánchez, Pedro, Romero, Jose Luis, Martin-Liberal, Juan, Lucas, Anna, Díaz-Beveridge, Roberto, Conde-Moreno, Antonio-José, Gala, Maria del Carmen Álamo de la, García-Castaño, Almudena, Prada, Pedro José, Cao, María González, Puertas, Enrique, Vidal, Joana
Zdroj: Neuro-Oncology; Nov2024, Vol. 26 Issue 11, p2074-2083, 10p
Databáze: Complementary Index